Luteolin-7-rutinoside Catalog No.:M32902-C InChi: InChI=1S/C36H49NO12/c1-8-37-16-33(17-43-4)22(47-18(2)38)14-23(44-5)35-21-15-34(42)30(48-32(41)20-12-10-9-11-13-20)24(21)36(49-19(3)39

InChi: InChI=1S/C36H49NO12/c1-8-37-16-33(17-43-4)22(47-18(2)38)14-23(44-5)35-21-15-34(42)30(48-32(41)20-12-10-9-11-13-20)24(21)36(49-19(3)39

inhibiting growth

leads to dose-dependent tumor growth inhibition (TGI: 76% and 84% for 10 mg/kg and 30 mg/kg)

Cytotoxic and Antitumor Effects of Curzerene from Curcuma longa

Etomoxir has also been identified as a direct agonist of PPARα

Luteolin-7-rutinoside Catalog No.:M32902-C InChi: InChI=1S/C36H49NO12/c1-8-37-16-33(17-43-4)22(47-18(2)38)14-23(44-5)35-21-15-34(42)30(48-32(41)20-12-10-9-11-13-20)24(21)36(49-19(3)39Luteolin 7 rutinoside has both anti arthritic and antifungal activities, can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection. Product information CAS Number: 20633 84 5 Molecular Weight: 594. 52 Formula: C27H30O15 Chemical Name: 2 (3,4 dihydroxyphenyl) 5 hydroxy 7 {[(2S,3R,4S,5S,6R) 3,4,5 trihydroxy 6 ({[(2R,3R,4R,5R,6S) 3,4,5 trihydroxy 6 methyloxan 2 yl]oxy}methyl)oxan 2 yl]oxy} 4H chromen 4 one